Len Blavatnik's Net Worth

Trade with PublicCompare Brokers
$0

Estimate Recalculated Dec 5, 2025 07:23PM EST

Who is Len Blavatnik

Len Blavatnik does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include LyondellBasell Industries N.V., Warner Music Group Corp., Square, Inc., Day One Biopharmaceuticals, Inc., Eliem Therapeutics, Inc., Gamida Cell Ltd., DigitalOcean Holdings, Inc., Neon Therapeutics, Inc., Loxo Oncology, Inc., EP Energy Corp, Anchiano Therapeutics Ltd., Verona Pharma plc, Disc Medicine, Inc., Pandion Therapeutics Holdco LLC, and VYNE Therapeutics Inc..

SEC CIK

Len Blavatnik's CIK is 0001326628

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

LyondellBasell Industries N.V.

Investor
Updated Feb 29, 2024
Form 4
-9.26%
-20.85K
——
Feb 29, 2024
65.29M
Disposition
—Feb 27
Form 4
-3.48%
-205.02K
$97.89
-$20.07M
Feb 21, 2024
65.31M
Sale
—Feb 16
Form 4
-1.02%
-450.00K
$99.61
-$648.55K
Aug 14, 2023
65.51M
Sale
—Aug 10 - Aug 11
Form 4
-28.51%
-761.00K
——
May 15, 2023
65.96M
Grant
—May 11
Form 4
-1.47%
-1.43M
$84.93
-$121.30M
Dec 05, 2022
115.16M
Sale
—Dec 01 - Dec 02
Form 4
-0.93%
-1.40M
$84.95
-$119.14M
Nov 30, 2022
168.13M
Sale
—Nov 28 - Nov 30
Form 4/A
0.00%
-27.00
$86.47
-$2.33K
Nov 18, 2022
767.08K
Sale
—Nov 15
Form 4
-0.25%
-127.44K
$86.48
-$11.02M
Nov 17, 2022
70.15M
Sale
—Nov 15
Form 4
-5.82%
-249.60K
$77.84
$311.34K
Nov 03, 2022
70.28M
Grant
—Jun 13 - Nov 01
Form 4
-1.78%
-927.00K
$108.11
-$100.21M
May 06, 2021
70.53M
Sale
—May 04
Form 4
—
—
——
Mar 09, 2021
71.46M
Acq/Dis
—Mar 05
Form 4
-1.84%
-975.29K
$106.63
-$100.76M
Mar 03, 2021
71.46M
Sale
—Mar 01
Form 4
-0.01%
-4.50K
$107.35
-$483.06K
Mar 01, 2021
72.43M
Sale
—Feb 25
Form 4
-1.66%
-714.50K
$106.45
-$76.06M
Feb 26, 2021
72.44M
Sale
—Feb 24
Form 4
-1.10%
-478.06K
$103.10
-$49.29M
Feb 25, 2021
73.15M
Sale
—Feb 23
Form 4
-0.80%
-350.00K
$103.38
-$36.18M
Feb 24, 2021
73.63M
Sale
—Feb 22
Form 4
-0.72%
-393.78K
$95.61
-$37.65M
Feb 17, 2021
73.98M
Sale
—Feb 12
Form 4
-0.10%
-55.54K
$95.41
-$5.30M
Feb 16, 2021
74.37M
Sale
—Feb 11
Form 4
-1.30%
-720.68K
$95.84
-$69.07M
Feb 12, 2021
74.43M
Sale
—Feb 10
Form 4
-0.92%
-518.69K
$88.59
-$45.95M
Dec 08, 2020
75.15M
Sale
—Dec 04
Form 4
-3.07%
-1.78M
$86.10
-$153.16M
Dec 03, 2020
75.67M
Sale
—Dec 01 - Dec 03
Form 4
-0.02%
-10.80K
$86.63
-$935.91K
Dec 02, 2020
77.45M
Sale
—Mar 18 - Nov 30
Form 4
14.99%
764.50K
$74.61
$57.04M
Sep 03, 2019
77.46M
Purchase
—Aug 29 - Sep 03
Form 4
75.08%
2.19M
$95.60
$209.08M
Nov 13, 2018
76.69M
Purchase
—Nov 09 - Nov 13
Form 4
122.27%
1.60M
$95.65
$153.27M
Nov 08, 2018
74.51M
Purchase
—Nov 06 - Nov 08
Form 4
—
1.31M
$92.35
$121.04M
Nov 05, 2018
72.90M
Purchase
—Nov 01 - Nov 05
Form 4
-1.26%
-139.62K
$89.12
-$12.44M
Mar 10, 2017
73.04M
Sale
—Mar 09
Form 4
-1.10%
-246.21K
$93.91
-$23.19M
Mar 03, 2017
84.29M
Sale
—Mar 01 - Mar 02
Form 4
-0.13%
-14.17K
$94.55
-$1.34M
Feb 24, 2017
73.43M
Sale
—Feb 22
Form 4
-4.73%
-1.17M
$92.35
-$107.79M
Feb 14, 2017
85.63M
Sale
—Feb 10 - Feb 13
Form 4
-4.13%
-3.03M
$92.60
-$279.76M
Feb 09, 2017
132.55M
Sale
—Feb 07 - Feb 09
Form 4
-3.40%
-4.50M
$82.29
-$172.83M
Mar 10, 2016
163.82M
Sale
—Mar 08 - Mar 09
Form 4
-2.77%
-4.00M
$92.33
-$369.40M
Oct 30, 2015
176.25M
Sale
—Oct 28 - Oct 30
Form 4
-2.56%
-4.00M
$102.54
-$409.15M
Jun 04, 2015
188.17M
Sale
—Jun 02 - Jun 03
Form 4
13.29%
8.50M
$67.71
$575.54M
Aug 02, 2013
88.94M
Purchase
—Jul 31
Form 4
-11.06%
-23.03K
$44.02
-$1.01M
Feb 28, 2012
80.44M
Sale
—Feb 24
Form 4
-11.06%
-9.98M
$44.01
-$439.06M
Feb 16, 2012
80.47M
Sale
—Feb 14 - Feb 15
Form 4
—
—
$28.00
—
Feb 23, 2011
90.44M
Purchase
—Feb 22
Form 4
—
—
$28.00
$956.84M
Jan 24, 2011
90.44M
Options
—Jan 24
Form 3
————
Jan 10, 2011
56.27M
—
——
Showing 40 results

Warner Music Group Corp.

Investor
Updated Mar 16, 2023
Form 4
-34.18%
-125.00M
——
Mar 16, 2023
241.19M
Grant
—Mar 06
Form 4
-69.02%
-1.09M
——
Jan 31, 2022
366.19M
Disposition
—Jan 27
Form 4
-2.29%
-8.56M
$40.66
-$348.15M
Jan 07, 2022
367.28M
Sale
—Jan 06
Form 4
14.45%
730.04K
$41.25
-$171.63M
Dec 10, 2021
375.84M
Sell-Options
—Dec 08
Form 4
-0.63%
-2.34M
$43.73
-$102.33M
Sep 28, 2021
371.65M
Sale
—Sep 24
Form 4
-0.84%
-3.15M
$37.75
-$118.92M
Sep 10, 2021
373.99M
Sale
—Sep 08
Form 4
-1.25%
-4.75M
$38.25
-$181.86M
Feb 12, 2021
377.14M
Sale
—Feb 10
Form 3/A————
Feb 12, 2021
—
—
——
Form 4
-2.85%
-11.21M
$25.00
-$280.22M
Jul 09, 2020
381.90M
Sale
—Jul 07
Form 4
-15.78%
-74.73M
$25.00
-$1.37B
Jun 05, 2020
398.89M
Sale
—Jun 02 - Jun 05
Form 3
————
Jun 02, 2020
—
—
——
Form 4
—
3.53M
——
May 08, 2007
3.53M
Acq/Dis
—May 07
Form 3
————
May 11, 2005
—
—
——
Showing 13 results

Square, Inc.

Investor
Updated Nov 25, 2015
Form 3
————
Nov 25, 2015
—
—
——
Showing 1 results

Day One Biopharmaceuticals, Inc.

Investor
Updated Oct 20, 2023
Form 4
12.88%
1.48M
$10.15
$14.98M
Oct 20, 2023
12.93M
Purchase
—Oct 18 - Oct 20
Form 4
7.20%
769.23K
$13.00
$10.00M
Jun 12, 2023
11.45M
Purchase
—Jun 09
Form 4
12.65%
1.20M
$15.00
$18.00M
Jun 21, 2022
10.68M
Purchase
—Jun 17
Form 4
1.14%
106.86K
$14.52
$1.55M
Jan 20, 2022
9.48M
Purchase
—Jan 18 - Jan 20
Form 4
10.29%
875.00K
$16.00
—
Jun 03, 2021
9.38M
Purchase
—Jun 01
Form 3
————
May 26, 2021
—
—
——
Showing 6 results

Eliem Therapeutics, Inc.

Investor
Updated Aug 16, 2021
Form 4
19.01%
800.00K
$12.50
$10.00M
Aug 16, 2021
5.01M
Purchase
—Aug 12
Form 3
————
Aug 09, 2021
—
—
——
Showing 2 results

Gamida Cell Ltd.

Investor
Updated Jan 13, 2022
Form 3/A————
Jan 13, 2022
—
—
——
Form 3
————
Jan 11, 2022
9.74M
—
——
Showing 2 results

DigitalOcean Holdings, Inc.

Investor
Updated Mar 30, 2021
Form 4
8.96%
2.13M
$47.00
$100.00M
Mar 30, 2021
25.87M
Purchase
—Mar 25
Form 3
————
Mar 23, 2021
23.74M
—
——
Showing 2 results

Neon Therapeutics, Inc.

Investor
Updated Mar 25, 2020
Form 4
-6.39%
-252.04K
$2.19
-$552.80K
Mar 25, 2020
3.69M
Sale
—Mar 23 - Mar 24
Form 4
-3.01%
-93.39K
$2.37
-$209.66K
Mar 23, 2020
3.00M
Sale
—Mar 19 - Mar 20
Form 4
-77.74%
-10.82M
$16.00
—
Jul 03, 2018
3.10M
Buy-Options
—Jun 29
Form 3
————
Jun 26, 2018
—
—
——
Showing 4 results

Loxo Oncology, Inc.

Investor
Updated Aug 06, 2014
Form 4
—
—
——
Aug 06, 2014
1.37M
Options
—Aug 06
Form 3
————
Jul 31, 2014
—
—
——
Showing 2 results

EP Energy Corp

Investor
Updated Jan 23, 2014
Form 4
—
3.67M
$18.15
$66.54M
Jan 23, 2014
34.94M
Purchase
—Jan 21
Form 3/A————
Jan 23, 2014
—
—
——
Form 3
————
Jan 16, 2014
31.28M
—
——
Showing 3 results

Anchiano Therapeutics Ltd.

Investor
Updated Jan 02, 2020
Form 3
————
Jan 02, 2020
13.43M
—
——
Showing 1 results

Verona Pharma plc

Investor
Updated Aug 17, 2022
Form 4
9.39%
4.80M
$1.31
$6.30M
Aug 17, 2022
55.91M
Purchase
—Aug 15
Form 3
————
Aug 17, 2022
51.11M
—
——
Showing 2 results

Disc Medicine, Inc.

Investor
Updated Jun 20, 2024
Form 4
13.26%
416.67K
$36.00
$15.00M
Jun 20, 2024
3.56M
Grant
—Jun 17
Form 4
—
204.08K
$49.00
$10.00M
Jun 20, 2023
204.08K
Purchase
—Jun 16
Form 4
16.06%
434.78K
$23.00
$10.00M
Feb 17, 2023
3.14M
Purchase
—Feb 15
Form 3
————
Jan 09, 2023
2.71M
—
——
Showing 4 results

Pandion Therapeutics Holdco LLC

Investor
Updated Jul 16, 2020
Form 3
————
Jul 16, 2020
—
—
——
Showing 1 results

VYNE Therapeutics Inc.

Investor
Updated Nov 13, 2023
Form 3
————
Nov 13, 2023
1.12M
—
——
Showing 1 results

Upstream Bio, Inc.

Investor
Updated Oct 17, 2024
Form 4
27.20%
1.18M
$17.00
—
Oct 17, 2024
5.49M
Purchase
—Oct 15
Showing 1 results
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved